Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» prostate cancer
prostate cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
CP Wire
Thu, 12/20/18 - 10:27 am
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
Thu, 12/20/18 - 10:19 am
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Sophiris, Stock Sliding After Cancer Drug Data, Still Plans Phase 3
Xconomy
Mon, 12/17/18 - 08:18 pm
Sophris
prostate cancer
clinical trials
Topsalysin
J&J shares fall after court refuses to block Zytiga generics
Pharmaforum
Fri, 11/23/18 - 01:14 pm
JNJ
generics
Zytiga
prostate cancer
Cellanyx Publishes Clinical Proof-of-Concept Study of First-in-Class Biomarker Test to Determine Prostate Cancer Risk
CP Wire
Wed, 11/21/18 - 10:32 am
Cellanyx
prostate cancer
biomarkers
diagnostics
Cellanyx Publishes Clinical Proof-of-Concept Study of First-in-Class Biomarker Test to Determine Prostate Cancer Risk
Wed, 11/21/18 - 10:06 am
Cellanyx
prostate cancer
Pfizer's PARP, androgen inhibitors next combo partners for NKTR-214
BioCentury
Tue, 11/6/18 - 11:35 am
Pfizer
Nektar Therapeutics
NKTR-214
Xtandi
Talzenna
Bavencio
prostate cancer
FDA Clears Two IND Applications for Fortis Therapeutics Novel Anti-CD46 Candidate for Prostate Cancer and Multiple Myeloma
CP Wire
Tue, 11/6/18 - 09:31 am
Fortis Therapeutics
prostate cancer
Multiple Myeloma
FDA Clears Two IND Applications for Fortis Therapeutics Novel Anti-CD46 Candidate for Prostate Cancer and Multiple Myeloma
Tue, 11/6/18 - 09:23 am
Fortis Therapeutics
prostate cancer
Multiple Myeloma
Zytiga generics looming as US court nixes J&J patent
Pharmaforum
Mon, 10/29/18 - 09:30 am
JNJ
Zytiga
generics
prostate cancer
Bayer plans filings for prostate cancer drug darolutamide
Pharmaforum
Wed, 10/24/18 - 10:09 am
Bayer
darolutamide
prostate cancer
Pfizer
JNJ
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
prostate cancer
JNJ
Zytiga
Erleada
Pfizer
Astellas
Xtandi
AbbVie
Lupron
Endocyte
Lu-PSMA-617
Boston Scientific inks $600M Augmenix buyout
Biopharma Dive
Fri, 09/7/18 - 10:55 am
devices
Boston Scientific
Augmenix
prostate cancer
M&A
Sophiris says it’s ready to get back on track with lead drug after patient death — but questions linger
Endpoints
Wed, 08/29/18 - 10:23 am
Sophris
Topsalysin
prostate cancer
Pfizer, Astellas revise two cancer drug trial protocols to speed up results
Yahoo/Reuters
Wed, 08/22/18 - 06:05 pm
Pfizer
Astellas
clinical trials
Xtandi
prostate cancer
Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population
Yahoo/Zacks.com
Mon, 07/16/18 - 09:40 am
Pfizer
FDA
Astellas
Xtandi
prostate cancer
Sudden death forces Sophiris to halt followup therapy in prostate cancer study — shares crushed
Endpoints
Mon, 06/25/18 - 12:47 pm
Sophris
prostate cancer
Topsalysin
clinical trials
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
CP Wire
Wed, 06/20/18 - 09:18 am
OncBioMune
ProscaVax
prostate cancer
vaccines
clinical trials
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
Wed, 06/20/18 - 09:10 am
OncBioMune
prostate cancer
ProscaVax
ASCO: AstraZeneca pioneer Lynparza scores with Zytiga combo in prostate cancer
Fierce Pharma
Tue, 06/5/18 - 10:34 pm
AstraZeneca
Lynparza
prostate cancer
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »